Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DN-101 plus Docetaxel in AIPC
NCT00043576Phase 3Unknown
- Sponsor
- Novacea
- Start
- Aug 2002
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 3 trial of calcitriol in prostate cancer (PCa), sponsored by Novacea. Status: unknown.
02
Drugs
calcitriol
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00043576.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00043576.